Back to Report Store Home

Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity

  • Published: Aug-2013
  • Report Code: GBIHC302MR
  • Report Format: pdf

Description

List of Figures

List of Figures

Figure 1: Obesity, Global, Prevalence (%), 1990–2010

Figure 2: Effects of Topiramate on Food Intake

Figure 3: Obesity Therapeutics Market, Obesity Drug Approvals and Market Removals

Figure 4: Obesity Therapeutics Market, Heat Map Comparing the Safety and Efficacy of Marketed Drugs

Figure 5: Obesity Therapeutics Market, Heat Map Comparing the Performance of Marketed Drugs in

Major Safety Parameters

Figure 6: Obesity Therapeutics Market, Global, Pipeline by Phase and Molecule Type and Molecular

Target

Figure 7: Obesity Therapeutics Market, Global, Clinical Trial Duration by Phase and Molecule Type, 2006–

2013

Figure 8: Obesity Therapeutics Market: Global, Clinical Trial Size by Phase and Molecule Type, 2006–2013

Figure 9: Obesity Therapeutics Market, Global, Clinical Trial Failure and Attrition Rates by Phase and

Molecule Type, 2006–2013

Figure 10: Obesity Therapeutics Market, Global, Clinical Trial Primary and Secondary Endpoints, 2006–2013

Figure 11: Heat Map Comparing the Safety and Efficacy of Marketed and Key Pipeline Drugs

Figure 12: Heat Map Comparing the Performance of Marketed and Key Pipeline Drugs in Major Safety

Parameters

Figure 13: Obesity Therapeutics Market, Global, Epidata and Market Forecasts, 2012–2019

Figure 14: Obesity Therapeutics Market, US, Epidata and Market Forecasts, 2012–2019

Figure 15: Obesity Therapeutics Market, Europe, Treatment Patterns, 2012–2019

Figure 16: Obesity Therapeutics Market, Europe, Annual Cost of Therapy, 2012–2019

Figure 17: Obesity Therapeutics Market, Europe, Market Forecasts, 2012–2019

Figure 18: Obesity Therapeutics Market, Japan, Epidata and Market Forecast, 2012–2019

Figure 19: Obesity Therapeutics Market, Global, Status, Value and Number of Licensing Deals, 2006–2013

Figure 20: Obesity Therapeutics Market, Global, Licensing Deals by Phase, Molecule Type and Value, 2006–

2013

Figure 21: Obesity Therapeutics Market, Global, Status, Value and Number of Co-development Deals,

2006–2011

Figure 22: Obesity Market, Global, GBI Research Market Sizing Model

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards